atezolizumab,carboplatin
roche
['atezo', 'imvigor130', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'carboplatin']
 presenting the final os analysis from imvigor130 trial atezo/placebo +platinum in myc #gu23 trend for os benefit but not statistically significant. 
GU oncologist, clinical trialist, Director GU Oncology @CleclinicMD Tweets my own, RT/Likes not active endorsement.